Literature DB >> 27941529

CHANGE OF CHOROIDAL VOLUME IN UNTREATED CENTRAL SEROUS CHORIORETINOPATHY.

Laura Pertl1, Anton Haas, Silke Hausberger, Tamara Pichler, Dieter F Rabensteiner, Gerald Seidel, Eva M Malle, Martin Weger.   

Abstract

PURPOSE: Choroidal hyperpermeability plays a central role in the pathophysiology of central serous chorioretinopathy (CSC). In active CSC undergoing treatment, choroidal thickness decreases if subretinal fluid (SRF) resolves. This study aimed to investigate the change in choroidal thickness and volume in eyes with untreated CSC.
METHODS: The authors retrospectively analyzed 27 eyes with treatment-naïve CSC (25 patients), who had a follow-up of 4 to 6 weeks. Retinal and choroidal volume and SRF were segmented manually and calculated using the Spectralis OCT built-in software (Spectralis; Heidelberg Engineering).
RESULTS: In treatment-naïve eyes with CSC, an increase in SRF was significantly associated with an increase in choroidal thickness and volume (rho = 0.93, P < 0.01). Eyes with greater baseline choroidal volume showed a significantly greater decrease in SRF during follow-up (rho = -0.47, P = 0.03).
CONCLUSION: In this study, an increase in SRF was associated with an increase in both choroidal thickness and volume in eyes with treatment-naïve CSC. Eyes with thicker baseline choroidal volume showed a greater reduction in SRF.

Entities:  

Mesh:

Year:  2017        PMID: 27941529     DOI: 10.1097/IAE.0000000000001408

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  3 in total

Review 1.  Evaluation of the choriocapillaris after photodynamic therapy for chronic central serous chorioretinopathy. A review of optical coherence tomography angiography (OCT-A) studies.

Authors:  Evita Evangelia Christou; Panagiotis Stavrakas; Vassilios Kozobolis; Andreas Katsanos; Ilias Georgalas; Maria Stefaniotou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-19       Impact factor: 3.117

2.  The association between visual function and retinal structure in chronic central serous chorioretinopathy.

Authors:  Aya Sugiura; Ryosuke Fujino; Nobuko Takemiya; Kimiko Shimizu; Masato Matsuura; Hiroshi Murata; Tatsuya Inoue; Ryo Obata; Ryo Asaoka
Journal:  Sci Rep       Date:  2017-11-24       Impact factor: 4.379

Review 3.  Biomarkers for central serous chorioretinopathy.

Authors:  Gideon Nkrumah; Manuel Paez-Escamilla; Sumit Randhir Singh; Mohammed Abdul Rasheed; Dmitri Maltsev; Abhilash Guduru; Jay Chhablani
Journal:  Ther Adv Ophthalmol       Date:  2020-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.